SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 344 filers reported holding SAREPTA THERAPEUTICS INC in Q4 2018. The put-call ratio across all filers is 0.66 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $135,279 | -42.6% | 1,116 | -50.2% | 0.01% | +20.0% |
| Q2 2023 | $235,612 | +40876.0% | 2,240 | +37233.3% | 0.01% | – |
| Q1 2023 | $575 | +2638.1% | 6 | -97.3% | 0.00% | -100.0% |
| Q4 2022 | $21 | -99.9% | 219 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $21,000 | +950.0% | 219 | +1052.6% | 0.00% | – |
| Q2 2022 | $2,000 | -66.7% | 19 | -59.6% | 0.00% | – |
| Q1 2022 | $6,000 | +50.0% | 47 | +67.9% | 0.00% | – |
| Q4 2021 | $4,000 | 0.0% | 28 | 0.0% | 0.00% | – |
| Q3 2021 | $4,000 | – | 28 | +2700.0% | 0.00% | – |
| Q2 2021 | $0 | – | 1 | – | 0.00% | – |
| Q1 2021 | $0 | -100.0% | 0 | -100.0% | 0.00% | – |
| Q4 2020 | $2,000 | +100.0% | 9 | 0.0% | 0.00% | – |
| Q3 2020 | $1,000 | 0.0% | 9 | 0.0% | 0.00% | – |
| Q2 2020 | $1,000 | – | 9 | – | 0.00% | – |
| Q1 2020 | $0 | – | 0 | – | 0.00% | – |
| Q4 2019 | $0 | -100.0% | 0 | -100.0% | 0.00% | -100.0% |
| Q3 2019 | $38,000 | +1800.0% | 500 | +4445.5% | 0.00% | – |
| Q1 2019 | $2,000 | -97.5% | 11 | -98.5% | 0.00% | -100.0% |
| Q4 2018 | $80,000 | -70.0% | 742 | -55.1% | 0.01% | -54.5% |
| Q3 2018 | $267,000 | +71.2% | 1,654 | +40.2% | 0.01% | +57.1% |
| Q2 2018 | $156,000 | +92.6% | 1,180 | -18.7% | 0.01% | +75.0% |
| Q1 2018 | $81,000 | 0.0% | 1,451 | 0.0% | 0.00% | 0.0% |
| Q4 2017 | $81,000 | +2.5% | 1,451 | -16.2% | 0.00% | +33.3% |
| Q3 2017 | $79,000 | +54.9% | 1,732 | +13.9% | 0.00% | +50.0% |
| Q2 2017 | $51,000 | +112.5% | 1,520 | +88.8% | 0.00% | +100.0% |
| Q1 2017 | $24,000 | -38.5% | 805 | -43.3% | 0.00% | -50.0% |
| Q4 2016 | $39,000 | -69.3% | 1,421 | -31.4% | 0.00% | -71.4% |
| Q3 2016 | $127,000 | +64.9% | 2,071 | -48.9% | 0.01% | +75.0% |
| Q2 2016 | $77,000 | +3750.0% | 4,050 | +36718.2% | 0.00% | – |
| Q1 2016 | $2,000 | -99.5% | 11 | -99.9% | 0.00% | -100.0% |
| Q4 2015 | $426,000 | – | 11,040 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Perceptive Advisors | 2,878,979 | $69,182,000 | 7.27% |
| Eventide Asset Management | 259,100 | $6,226,000 | 0.97% |
| GLADE BROOK CAPITAL PARTNERS LLC | 251,000 | $6,032,000 | 0.93% |
| IMS Capital Management | 32,215 | $774,000 | 0.91% |
| Perceptive Advisors | 350,000 | $8,413,000 | 0.88% |
| Benchmark Capital Advisors | 34,900 | $839,000 | 0.58% |
| BECK CAPITAL MANAGEMENT, LLC | 24,744 | $636,000 | 0.49% |
| SABBY MANAGEMENT, LLC | 352,100 | $8,461,000 | 0.47% |
| Hatteras Alternative Mutual Funds, LLC | 39,404 | $947,000 | 0.46% |
| Potomac Capital Management, Inc. | 22,100 | $531,000 | 0.45% |